West Nile virus

CMAJ. Canadian Medical Association Journal

Volumn 173, Issue 5, 2005, Pages 484-

  Murray, Sally ^a   Weir, Erica ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ASIA; AUTUMN; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CROSS REACTION; DISEASE CARRIER; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EUROPE; HIGH RISK PATIENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION CONTROL; ISRAEL; NONHUMAN; SERODIAGNOSIS; SHORT SURVEY; SOUTH AFRICA; SUMMER; SYMPTOMATOLOGY; TRAVEL; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

EID: 24044538932     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050930     Document Type: Short Survey

References (3)

1. Nosal B, Pellizzari R. West Nile virus. CMAJ 2003;168(11):1443.
2. Centre for Disease Control. West Nile virus infection: information for clinicians. Available: www.cdc.gov/ncidod /dvbid/westnile/clinicians/treatment. htm (accessed 2005 Jul 18).
3. Public Health Agency of Canada. Safety tips on using personal insect repellents. Available: www.hc-sc.gc.ca/hpb/lcdc/wn-no/repellents-insectifuge_e. html (accessed 2005 Jul 18).